top of page

Neuroscience News & Opinion

1 dic. 2025

Ozempic for the Brain? Inside Semaglutide’s Ambitious and Paused Alzheimer’s Trial

Clinical trial insights and biological rationale behind semaglutide’s investigation in early Alzheimer’s disease.

Read More

27 feb. 2025

Eli Lilly's $27 Billion U.S. Investment: A Game Changer?

​

Read More

23 feb. 2025

New Insights into Alzheimer’s Disease Detection with Blood Biomarkers

​

Read More

12 mar. 2025

New Findings on Sex Differences in Alzheimer's Disease Progression!

​

Read More

28 mar. 2025

EU Rejects Lilly's Alzheimer's Treatment, Kisunla (donanemab)

​

Read More

19 mar. 2025

Brains in Crisis: Neurological Conditions Become the World's Leading Health Burden

​

Read More

6 dic. 2025

Long-term LEQEMBI® treatment slows Alzheimer’s disease progression – a hope for longevity!

Benefits of Lecanemab Treatment in Slowing Disease Progression and safety & efficacy of lecanemab subcutaneous (SC) - autoinjector clinical program.

Read More
An old person getting consultation from a woman clinician.
bottom of page